Accelr8 to Hold 2012 Annual Meeting of Shareholders; Product
Development Continues with Launch Expected in 2015
DENVER, Dec. 11, 2012 /PRNewswire/ -- Accelr8
Technology Corporation (NYSE MKT: AXK) will hold its 2012 Annual
Meeting of Shareholders (the "Annual Meeting") at 2:30 p.m., local time, on Wednesday, December 12, 2012, at the Warwick
Hotel Denver, 1776 Grant Street, Denver,
Colorado 80203.
Progress towards the company's IVD product launch continues,
with management expecting to be in development through 2014,
launching in 2015, with additional clinical trials continuing
through 2016.
About Accelr8
Accelr8 Technology Corporation (www.accelr8.com) is focused on
developing and commercializing innovative instrumentation for the
rapid identification and antibiotic susceptibility testing of
infectious pathogens. The Company's BACcel™
platform utilizes a proprietary culture-free process with both
genomic and phenotypic detection technologies that decrease time to
result while maintaining high sensitivity and
specificity.
Disclaimer Regarding Forward-Looking Statements
Certain statements in this news release may be "forward-looking
statements" within the meaning of Section 27A of the Securities Act
of 1933, as amended, and Section 21E of the Securities Exchange Act
of 1934, as amended. Statements regarding future prospects
and developments are based upon current expectations and involve
certain risks and uncertainties that could cause actual results and
developments to differ materially from the forward-looking
statement, including those detailed in the Company's filings with
the SEC. The Company does not undertake an obligation to
publicly update or revise any forward-looking statements, whether
as a result of new information or future events.
SOURCE Accelr8 Technology Corporation